柳氮磺吡啶单一疗法为那些长期患有各种疾病和没有不良预后特征的，包含那些不同严重程度患病的患者推荐。
Sulfasalazine monotherapy is recommended for patients with all disease durations and without poor prognostic features and includes those with all degrees of disease activity.
甲氨喋呤加柳氮磺吡啶疗法是推荐给那些患病时间长久，病情高度活动、但是没有不良预后特征的患者。
Methotrexate plus sulfasalazine is recommended in patients with all disease durations provided they have high disease activity and poor prognostic features.
羟氯喹加柳氮磺吡啶疗法是只推荐给那些患病时间中等(6 -24个月)，病情重但是没有不良预后特征的患者。
Hydroxychloroquine plus sulfasalazine is recommended only for patients with intermediate disease duration (6-24 months) and high disease activity but without poor prognostic features.
柳氮磺胺吡啶具有消炎和抗菌的性质，主要用于治疗溃疡性结肠炎和类风湿关节炎。
Sulfasalazine possesses both antiinflammatory and antibacterial properties and was mainly used to treat inflammatory bowel disease and rheumatoid arthritis.
非甾体抗炎药和柳氮磺吡啶是基本治疗药物。
Nonsteroidal anti-inflammatory drugs and sulfasalazine were the mainstay of treatment.
目的探讨在常规应用非甾体抗炎药的基础上应用柳氮磺胺吡啶，对强直性脊柱炎的治疗价值。
Objective to discuss the application of azulfidine to ankylosing spondylitis on the basis of non-steroids as anti-inflammatory agents.
在进行手术前(除急诊外)，应尝试使用药物如柳氮磺吡啶、激素、硫唑嘌呤、肿瘤坏死因子拮抗剂及反应停。
Agents such as sulfasalazine, corticosteroids, azathioprine, TNFa antagonists and thalidomide should be tried first before surgery, except in emergencies.
方法：165例溃疡性结肠炎患者随机分为治疗组和对照组，分别给予复方甘草酸苷和柳氮磺胺吡啶治疗，比较两组的临床疗效。
METHODS: 165cases of ulcerative colitis were divided into two groups: trial group (compound glycyrrhizin) and control group (sulfasalazine). The clinical effects were compared between two groups.
方法：165例溃疡性结肠炎患者随机分为治疗组和对照组，分别给予复方甘草酸苷和柳氮磺胺吡啶治疗，比较两组的临床疗效。
METHODS: 165cases of ulcerative colitis were divided into two groups: trial group (compound glycyrrhizin) and control group (sulfasalazine). The clinical effects were compared between two groups.
应用推荐